Published in Am Rev Respir Dis on July 01, 1990
New perspectives on basic mechanisms in lung disease. 6. Proteinase imbalance: its role in lung disease. Thorax (1993) 1.23
Collaborative interactions between neutrophil elastase and metalloproteinases in extracellular matrix degradation in three-dimensional collagen gels. Respir Res (2001) 1.02
The role of collagenase in emphysema. Respir Res (2001) 0.96
Burkholderia vaccines: are we moving forward? Front Cell Infect Microbiol (2013) 0.90
The link between chronic periodontitis and COPD: a common role for the neutrophil? BMC Med (2013) 0.83
Airways inflammation in subjects with chronic bronchitis who have never smoked. Thorax (1994) 0.82
Exhaled breath condensate adenosine tracks lung function changes in cystic fibrosis. Am J Physiol Lung Cell Mol Physiol (2013) 0.81
Neutrophil maturation rate determines the effects of dipeptidyl peptidase 1 inhibition on neutrophil serine protease activity. Br J Pharmacol (2016) 0.78
Effective DNA inhibitors of cathepsin g by in vitro selection. Int J Mol Sci (2008) 0.76
Chronic obstructive pulmonary disease effect on the prevalence and postoperative outcome of abdominal aortic aneurysms: A meta-analysis. Sci Rep (2016) 0.75
Biomarkers of extracellular matrix turnover are associated with emphysema and eosinophilic-bronchitis in COPD. Respir Res (2017) 0.75
Laminin--a glycoprotein from basement membranes. J Biol Chem (1979) 12.49
A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med (1999) 10.62
Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution. J Appl Physiol (1985) (1986) 6.86
Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J (2008) 5.38
Interstitial lung diseases of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract (first of two parts). N Engl J Med (1984) 3.73
Distribution and immunoelectron microscopic localization of laminin, a noncollagenous basement membrane glycoprotein. Lab Invest (1980) 3.64
Isolation of a heparan sulfate-containing proteoglycan from basement membrane. Proc Natl Acad Sci U S A (1980) 3.57
Chicken soup inhibits neutrophil chemotaxis in vitro. Chest (2000) 3.48
Enzyme-linked immunoassay (ELISA) for connective tissue components. Anal Biochem (1980) 3.28
Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma. JAMA (1994) 3.03
New enzyme immunoassays for measurement of influenza A/Victoria/3/75 virus in nasal washes. Lancet (1980) 2.35
Production of fibronectin by the human alveolar macrophage: mechanism for the recruitment of fibroblasts to sites of tissue injury in interstitial lung diseases. Proc Natl Acad Sci U S A (1981) 2.34
Human alveolar macrophage growth factor for fibroblasts. Regulation and partial characterization. J Clin Invest (1982) 2.33
Immunogenicity and smoking-cessation outcomes for a novel nicotine immunotherapeutic. Clin Pharmacol Ther (2011) 2.33
Interstitial lung diseases of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract. N Engl J Med (1984) 2.30
Human type III collagen gene expression is coordinately modulated with the type I collagen genes during fibroblast growth. Biochemistry (1986) 2.28
Antielastases of the human alveolar structures. Implications for the protease-antiprotease theory of emphysema. J Clin Invest (1981) 2.20
Cigarette smoke induces interleukin-8 release from human bronchial epithelial cells. Am J Respir Crit Care Med (1997) 2.12
Antibodies to laminin in Chagas' disease. J Exp Med (1982) 2.11
Familial idiopathic pulmonary fibrosis. Evidence of lung inflammation in unaffected family members. N Engl J Med (1986) 1.90
Modulation of alveolar macrophage-driven fibroblast proliferation by alternative macrophage mediators. J Clin Invest (1986) 1.82
Neutrophil chemotactic factors in bacterial pneumonia. Chest (1989) 1.69
Lower respiratory tract lactoferrin and lysozyme arise primarily in the airways and are elevated in association with chronic bronchitis. J Lab Clin Med (1990) 1.67
Pulmonary macrophages can stimulate cell growth of bovine bronchial epithelial cells. Am J Respir Cell Mol Biol (1990) 1.66
Regulation of ciliary beat frequency by both PKA and PKG in bovine airway epithelial cells. Am J Physiol (1998) 1.64
Pathogenesis of the granulomatous lung diseases. Am Rev Respir Dis (1984) 1.64
Role of fibronectin as a growth factor for fibroblasts. J Cell Biol (1983) 1.64
Normal human alveolar macrophages obtained by bronchoalveolar lavage have a limited capacity to release interleukin-1. J Clin Invest (1984) 1.61
Intraluminal airway inflammation in chronic bronchitis. Characterization and correlation with clinical parameters. Am Rev Respir Dis (1989) 1.58
Characterization of the lower respiratory tract inflammation of nonsmoking individuals with interstitial lung disease associated with chronic inhalation of inorganic dusts. Am Rev Respir Dis (1987) 1.57
Effects of aerosolized surfactant in patients with stable chronic bronchitis: a prospective randomized controlled trial. JAMA (1997) 1.56
Prostaglandin E(2) inhibits fibroblast chemotaxis. Am J Physiol Lung Cell Mol Physiol (2001) 1.55
Augmentation of functional prostaglandin E levels on the respiratory epithelial surface by aerosol administration of prostaglandin E. Am Rev Respir Dis (1991) 1.49
MR of the knee: the significance of high signal in the meniscus that does not clearly extend to the surface. AJR Am J Roentgenol (1991) 1.48
Neutrophilic respiratory tract inflammation and peripheral blood neutrophilia after grain sorghum dust extract challenge. Chest (1995) 1.42
Identification of members of the protein phosphatase 1 gene family in the rat and enhanced expression of protein phosphatase 1 alpha gene in rat hepatocellular carcinomas. Jpn J Cancer Res (1990) 1.42
The smoking cessation efficacy of varying doses of nicotine patch delivery systems 4 to 5 years post-quit day. Prev Med (1999) 1.42
Procollagen production and procollagen messenger RNA levels and activity in human lung fibroblasts during periods of rapid and stationary growth. J Biol Chem (1981) 1.41
Pulmonary oxygen toxicity. Early reversible changes in human alveolar structures induced by hyperoxia. N Engl J Med (1983) 1.38
Usefulness of a small scale indirect 125I-labelled protein A binding assay for detection of monoclonal antibodies against hematopoietic cell surface antigens. Leuk Res (1991) 1.38
Effect of transdermal nicotine delivery as an adjunct to low-intervention smoking cessation therapy. A randomized, placebo-controlled, double-blind study. Arch Intern Med (1991) 1.38
Regional distribution of emphysema: correlation of high-resolution CT with pulmonary function tests in unselected smokers. Radiology (1992) 1.36
Spontaneous release of interleukin 2 by lung T lymphocytes in active pulmonary sarcoidosis is primarily from the Leu3+DR+ T cell subset. J Clin Invest (1986) 1.35
Fibronectin in human bronchopulmonary lavage fluid. Elevation in patients with interstitial lung disease. J Clin Invest (1982) 1.31
Regulation of fibroblast proliferation in three-dimensional collagen gel matrix. In Vitro Cell Dev Biol Anim (1997) 1.28
Acetaldehyde-stimulated PKC activity in airway epithelial cells treated with smoke extract from normal and smokeless cigarettes. Proc Soc Exp Biol Med (2000) 1.25
Are higher doses of nicotine replacement more effective for smoking cessation? Nicotine Tob Res (1999) 1.22
Immunological functions of the pulmonary epithelium. Eur Respir J (1995) 1.22
Smoke and viral infection cause cilia loss detectable by bronchoalveolar lavage cytology and dynein ELISA. Am J Respir Crit Care Med (1994) 1.21
Hormonal requirements for basement membrane collagen deposition by cultured rat mammary epithelium. Lab Invest (1979) 1.20
Evidence for chronic inflammation as a component of the interstitial lung disease associated with progressive systemic sclerosis. Am Rev Respir Dis (1985) 1.20
Transplanted BM and BM side population cells contribute progeny to the lung and liver in irradiated mice. Cytotherapy (2003) 1.19
Maximum oxygen consumption and the ADAPT quality-of-life scale. Arch Phys Med Rehabil (1982) 1.18
Effect of collagen and cell shape on binding of fibronectin to cells. Arch Biochem Biophys (1981) 1.18
Clinical signs of normal plasma volume expansion during pregnancy. Am J Obstet Gynecol (1983) 1.16
Cigarette smoke inhibits lung fibroblast proliferation and chemotaxis. Am J Respir Crit Care Med (1995) 1.13
Patterns of pulmonary structural remodeling after experimental paraquat toxicity. The morphogenesis of intraalveolar fibrosis. Am J Pathol (1985) 1.13
Total indoor smoking ban and smoker behavior. Prev Med (1992) 1.12
Quantitative culture of bronchoalveolar lavage fluid for the diagnosis of bacterial pneumonia. Am J Med (1993) 1.12
Lower respiratory tract iron burden is increased in association with cigarette smoking. J Lab Clin Med (1991) 1.12
Bronchoscopy with bronchoalveolar lavage causes neutrophil recruitment to the lower respiratory tract. Am Rev Respir Dis (1991) 1.11
Paraquat-induced pulmonary fibrosis. Role of the alveolitis in modulating the development of fibrosis. Am Rev Respir Dis (1984) 1.11
Preparation of collagen substrates for cell attachment: effect of collagen concentration and phosphate buffer. Anal Biochem (1979) 1.09
NIH conference. Airway inflammation. Ann Intern Med (1995) 1.08
Cigarette smoke inhibits human bronchial epithelial cell repair processes. Am J Respir Cell Mol Biol (2001) 1.08
Complement activation by cigarette smoke. Am J Physiol (1991) 1.08
The role of cigarette smoke in the pathogenesis of asthma and as a trigger for acute symptoms. Curr Opin Pulm Med (1999) 1.07
Adhesion characteristics of murine metastatic and nonmetastatic tumor cells in vitro. Cancer Res (1980) 1.07
Small intestinal perforation in Wegener's granulomatosis. J Rheumatol (1989) 1.05
Contraction of fibroblast-containing collagen gels: initial collagen concentration regulates the degree of contraction and cell survival. In Vitro Cell Dev Biol Anim (2001) 1.04
Aerosolized beclomethasone in chronic bronchitis. Improved pulmonary function and diminished airway inflammation. Am Rev Respir Dis (1992) 1.04
An enzyme-linked immunoassay for the cartilage proteoglycan. Arch Biochem Biophys (1981) 1.04
Selective up-regulation of type II inosine 5'-monophosphate dehydrogenase messenger RNA expression in human leukemias. Cancer Res (1991) 1.04
Pathogenesis, evaluation, and therapy for massive hemoptysis. Clin Chest Med (1992) 1.02
Cytokine inhibition of fibroblast-induced gel contraction is mediated by PGE(2) and NO acting through separate parallel pathways. Am J Respir Cell Mol Biol (2001) 1.02
Collaborative interactions between neutrophil elastase and metalloproteinases in extracellular matrix degradation in three-dimensional collagen gels. Respir Res (2001) 1.02
Airway epithelial cells: functional roles in airway disease. Am J Respir Crit Care Med (1994) 1.01
Aprotinin and methylprednisolone equally blunt cardiopulmonary bypass-induced inflammation in humans. J Thorac Cardiovasc Surg (1995) 1.01
The Goodpasture-like syndrome in mice induced by intravenous injections of anti-type IV collagen and anti-laminin antibody. Am J Pathol (1982) 1.01
Cigarette smoke extract inhibits fibroblast-mediated collagen gel contraction. Am J Physiol (1998) 1.01
Decreased accumulation as a mechanism of resistance to cis-diamminedichloroplatinum(II) in human non-small cell lung cancer cell lines: relation to DNA damage and repair. Cancer Res (1990) 1.00
Cyclooxygenase metabolites are compartmentalized in the human lower respiratory tract. J Appl Physiol (1985) (1987) 1.00
Respiratory tract responses to dust: relationships between dust burden, lung injury, alveolar macrophage fibronectin release, and the development of pulmonary fibrosis. Toxicol Appl Pharmacol (1990) 0.99
Synergistic neutrophil elastase-cytokine interaction degrades collagen in three-dimensional culture. Am J Physiol Lung Cell Mol Physiol (2001) 0.98
Adenosine A2A receptors promote adenosine-stimulated wound healing in bronchial epithelial cells. Am J Physiol Lung Cell Mol Physiol (2005) 0.97
Candidate genes for COPD in two large data sets. Eur Respir J (2010) 0.96
PDE4: a novel target in the treatment of chronic obstructive pulmonary disease. Clin Pharmacol Ther (2011) 0.95